0.8249
price down icon2.59%   -0.0219
 
loading
전일 마감가:
$0.8468
열려 있는:
$0.88
하루 거래량:
589.37K
Relative Volume:
0.54
시가총액:
$130.93M
수익:
-
순이익/손실:
$-41.23M
주가수익비율:
-1.1784
EPS:
-0.7
순현금흐름:
$-11.54M
1주 성능:
+1.98%
1개월 성능:
+15.39%
6개월 성능:
+26.93%
1년 성능:
-61.09%
1일 변동 폭
Value
$0.8018
$0.8849
1주일 범위
Value
$0.794
$0.89
52주 변동 폭
Value
$0.395
$3.38

Renovaro Inc Stock (RENB) Company Profile

Name
명칭
Renovaro Inc
Name
전화
45 39179840
Name
주소
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Name
직원
25
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
RENB's Discussions on Twitter

RENB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RENB
Renovaro Inc
0.8249 130.93M 0 -41.23M -11.54M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Renovaro Inc 주식(RENB)의 최신 뉴스

pulisher
Feb 20, 2025

Renovaro (NASDAQ:RENB) Posts Earnings Results - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow

Feb 20, 2025
pulisher
Feb 20, 2025

Renovaro: Fiscal Q2 Earnings Snapshot - CTPost

Feb 20, 2025
pulisher
Feb 19, 2025

Renovaro: Fiscal Q2 Earnings Snapshot -February 19, 2025 at 05:03 pm EST - Marketscreener.com

Feb 19, 2025
pulisher
Feb 19, 2025

RENOVARO INC. SEC 10-Q Report - TradingView

Feb 19, 2025
pulisher
Feb 19, 2025

Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing Shows - Marketscreener.com

Feb 19, 2025
pulisher
Feb 19, 2025

This AI Stock Is Up 50% in 2025. Is It Too Late to Buy? - The Globe and Mail

Feb 19, 2025
pulisher
Feb 15, 2025

SG Americas Securities LLC Boosts Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

Renovaro (NASDAQ:RENB) Stock Quotes, Forecast and News Summary - Benzinga

Feb 14, 2025
pulisher
Feb 13, 2025

AMC Networks (AMCX) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail

Feb 13, 2025
pulisher
Feb 10, 2025

Renovaro Biosciences Updates CEO Compensation Plan - TipRanks

Feb 10, 2025
pulisher
Feb 10, 2025

Renovaro Inc (RENB)’s Market Momentum: Closing Strong at 0.70, Up 4.32 - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

RENB (Renovaro Inc) may reap gains as insiders became active recently - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

After Falling -6.53% During The Past Week, Should You Still Buy Renovaro Inc (NASDAQ: RENB)? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Sagimet Biosciences Inc (NASDAQ:SGMT) Up 47.7% Since 52-Week Low; YTD Rose 1.56% – Here’s What You Need To Do – Marketing Sentinel - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 05, 2025

Renovaro Inc (RENB) Stock: From Low to High in 52 Weeks - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

Renovaro Inc. (NASDAQ:RENB) Stock Holdings Increased by JPMorgan Chase & Co. - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Quarterly Snapshot: Quick and Current Ratios for Renovaro Inc (RENB) - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Renovaro Inc (RENB)’s results reveal risk - US Post News

Feb 04, 2025
pulisher
Jan 26, 2025

Barclays PLC Has $34,000 Stock Position in Renovaro Inc. (NASDAQ:RENB) - Defense World

Jan 26, 2025
pulisher
Jan 19, 2025

Short Interest in Renovaro Inc. (NASDAQ:RENB) Rises By 30.7% - MarketBeat

Jan 19, 2025
pulisher
Jan 14, 2025

Renovaro Inc. appoints new CFO Nathen Fuentes - Investing.com India

Jan 14, 2025
pulisher
Jan 13, 2025

Renovaro Inc. appoints new CFO Nathen Fuentes By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 11, 2025

Geode Capital Management LLC Decreases Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World

Jan 11, 2025
pulisher
Jan 09, 2025

Renovaro To Buy Predictive Oncology in All-Stock Deal - Pulse 2.0

Jan 09, 2025
pulisher
Jan 09, 2025

Renovaro Biosciences Subsidiary Appoints New CEO - MSN

Jan 09, 2025
pulisher
Jan 08, 2025

Renovaro appoints Nathen Fuentes as finance chief - MSN

Jan 08, 2025
pulisher
Jan 08, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Predictive Oncology Inc.POAI - The Malaysian Reserve

Jan 08, 2025
pulisher
Jan 08, 2025

Renovaro Biosciences Merges with Predictive Oncology - MSN

Jan 08, 2025
pulisher
Jan 07, 2025

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc.POAI - Marketscreener.com

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Inc. appoints new CEO for subsidiary By Investing.com - Investing.com Australia

Jan 07, 2025
pulisher
Jan 07, 2025

Nathen Fuentes Joins Renovaro as Chief Financial Officer - citybiz

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro BioSciences issues shareholder letter, provides corporate update - TipRanks

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Taps Nathen Fuentes as Finance Chief - MarketWatch

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Issues Shareholder Letter and Provides Corporate Update - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Inc. appoints new CEO for subsidiary - Investing.com

Jan 07, 2025
pulisher
Jan 07, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders - GlobeNewswire

Jan 07, 2025
pulisher
Jan 06, 2025

Renovaro To Buy Predictive Oncology In All-Stock Deal - Pulse 2.0

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology shares rise 71% as takeover by Renovaro is announced - Mugglehead

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology - citybiz

Jan 06, 2025
pulisher
Jan 06, 2025

M&A: Predictive Oncology to be Acquired by Renovaro - HIT Consultant

Jan 06, 2025
pulisher
Jan 06, 2025

POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders - Business Wire

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to acquire Predictive Oncology in all-stock transaction - TipRanks

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology in All-Stock Transaction - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology in Deal to Be Sold to Renovaro - MarketWatch

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology in All-Stock Transaction - Benzinga

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology Announces Agreement to be Acquired by Renovaro - GlobeNewswire

Jan 06, 2025

Renovaro Inc (RENB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Renovaro Inc 주식 (RENB) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
William Anderson Wittekind
10% Owner
Jul 17 '24
Sale
1.46
16,362
23,889
841,433
William Anderson Wittekind
10% Owner
Jul 15 '24
Sale
1.41
21,954
30,955
875,795
William Anderson Wittekind
10% Owner
Jul 10 '24
Sale
1.51
75,000
113,250
894,645
William Anderson Wittekind
10% Owner
Jul 11 '24
Sale
1.51
14,896
22,493
897,749
William Anderson Wittekind
10% Owner
Jul 09 '24
Sale
1.53
4,630
7,084
969,645
William Anderson Wittekind
10% Owner
Jul 05 '24
Sale
1.55
60,000
93,000
974,275
William Anderson Wittekind
10% Owner
Jul 03 '24
Sale
1.51
50,000
75,500
1,034,275
William Anderson Wittekind
10% Owner
Jul 01 '24
Sale
1.56
60,000
93,600
1,118,828
William Anderson Wittekind
10% Owner
Jul 02 '24
Sale
1.54
34,553
53,212
1,084,275
William Anderson Wittekind
10% Owner
Jun 26 '24
Sale
1.57
50,000
78,500
1,193,499
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
자본화:     |  볼륨(24시간):